Why the study?
Does irbesartan improve ventricular and myocyte function in a canine model of developing left ventricular hypertrophy?
Population
17 dogs in a pacing-recovery model of developing left ventricular hypertrophy.
Comparison
Irbesartan 30 mg/kg twice daily administered… vs Untreated pacing-recovery group and sham controls.
Design
Preclinical, Randomly assigned
Follow-up
4 weeks (recovery period)
Authors
Loading...
AT1 blockade may modulate experimental LV remodeling; leaves open clinical translation in human hypertrophy.
Does irbesartan improve ventricular and myocyte function in a canine model of developing left ventricular hypertrophy?
In a canine model of pacing-induced heart failure, AT1 receptor blockade with irbesartan reduces LV mass and improves some indices of myocyte contractility, suggesting AT1 activation contributes to hypertrophic remodeling.
Spinale et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: